These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9750370)

  • 1. Bacterial phospholipases.
    Titball RW
    Symp Ser Soc Appl Microbiol; 1998; 27():127S-137S. PubMed ID: 9750370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a nontoxic variant of Clostridium perfringens α-toxin with the toxic wild-type strain.
    Vachieri SG; Clark GC; Alape-Girón A; Flores-Díaz M; Justin N; Naylor CE; Titball RW; Basak AK
    Acta Crystallogr D Biol Crystallogr; 2010 Oct; 66(Pt 10):1067-74. PubMed ID: 20944240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK; Melville SB
    Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial phospholipases C.
    Titball RW
    Microbiol Rev; 1993 Jun; 57(2):347-66. PubMed ID: 8336671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities.
    Walker N; Holley J; Naylor CE; Flores-Díaz M; Alape-Girón A; Carter G; Carr FJ; Thelestam M; Keyte M; Moss DS; Basak AK; Miller J; Titball RW
    Arch Biochem Biophys; 2000 Dec; 384(1):24-30. PubMed ID: 11147832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the calcium-binding C-terminal domain of Clostridium perfringens alpha-toxin.
    Naylor CE; Jepson M; Crane DT; Titball RW; Miller J; Basak AK; Bolgiano B
    J Mol Biol; 1999 Dec; 294(3):757-70. PubMed ID: 10610794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
    Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
    J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid metabolizing enzyme activities modulated by phospholipid substrate lateral distribution.
    Salinas DG; Reyes JG; De la Fuente M
    Bull Math Biol; 2011 Sep; 73(9):2045-67. PubMed ID: 21108012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development from actions of bacterial phospholipases C on eucaryotic plasma membranes to molecular biology of GPI-anchored proteins].
    Ikezawa H
    Yakugaku Zasshi; 1999 Jul; 119(7):472-94. PubMed ID: 10434800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipases and their industrial applications.
    De Maria L; Vind J; Oxenbøll KM; Svendsen A; Patkar S
    Appl Microbiol Biotechnol; 2007 Feb; 74(2):290-300. PubMed ID: 17221199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altering substrate specificity of phosphatidylcholine-preferring phospholipase C of Bacillus cereus by random mutagenesis of the headgroup binding site.
    Antikainen NM; Hergenrother PJ; Harris MM; Corbett W; Martin SF
    Biochemistry; 2003 Feb; 42(6):1603-10. PubMed ID: 12578373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.
    Sayeed S; Uzal FA; Fisher DJ; Saputo J; Vidal JE; Chen Y; Gupta P; Rood JI; McClane BA
    Mol Microbiol; 2008 Jan; 67(1):15-30. PubMed ID: 18078439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonessential activation and competitive inhibition of bacterial phosphatidylinositol-specific phospholipase C by short-chain phospholipids and analogues.
    Zhou C; Roberts MF
    Biochemistry; 1998 Nov; 37(46):16430-9. PubMed ID: 9819236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial Sphingomyelinases and Phospholipases as Virulence Factors.
    Flores-Díaz M; Monturiol-Gross L; Naylor C; Alape-Girón A; Flieger A
    Microbiol Mol Biol Rev; 2016 Sep; 80(3):597-628. PubMed ID: 27307578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disordered proteins: biological membranes as two-dimensional aggregation matrices.
    Byström R; Aisenbrey C; Borowik T; Bokvist M; Lindström F; Sani MA; Olofsson A; Gröbner G
    Cell Biochem Biophys; 2008; 52(3):175-89. PubMed ID: 18975139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.